Literature DB >> 22358549

Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells.

K Horiuchi1, H Tsurushima, B Soo Kim, S Qin Liu, K Saijo, Y Saijo, T Nukiwa, N Nomura, M Matsumura, T Ohno.   

Abstract

Human tumor specific cytotoxic T lymphocytes (CTL) were expanded on formalin-fixed autologous target tumor cells derived from glioblastoma multiforme. Growth response of the CTL restimulated with the fixed target cells was larger than those with live target cells. The results suggest that formalin-fixed tumor cells will be stable sources of tumor antigen for efficient autologous CTL expansion and be useful for adoptive immunotherapy of tumors.

Entities:  

Year:  1998        PMID： 22358549      PMCID： PMC3466675          DOI： 10.1023/A:1007903614475

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


  10 in total

Review 1.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

2.  Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.

Authors:  B A Tjoa; D M Kranz
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

3.  Tumor-specific autologous cytotoxic T lymphocytes from tissue sections.

Authors:  S Q Liu; H Shiraiwa; K Kawai; H Hayashi; H Akaza; B S Kim; A Oki; M Nishida; T Kubo; K Hashizaki; K Saijo; T Ohno
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

4.  Re.: Surface antigen preservation by PLP and formalin fixation and the effects of tissue processing.

Authors:  K Pollard; C S Holgate
Journal:  J Immunol Methods       Date:  1987-01-26       Impact factor: 2.303

5.  MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.

Authors:  N J Crowley; T L Darrow; M A Quinn-Allen; H F Seigler
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

6.  The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation.

Authors:  C A Holden; J Spaull; R Williams; C J Spry; R R Jones; E W Jones
Journal:  J Immunol Methods       Date:  1986-07-11       Impact factor: 2.303

7.  Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

Authors:  L M Muul; P J Spiess; E P Director; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

8.  Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections.

Authors:  S Q Liu; K Saijo; T Todoroki; T Ohno
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

9.  Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.

Authors:  K Kawai; T Sasaki; K Saijo-Kurita; H Akaza; K Koiso; T Ohno
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.

Authors:  T Wölfel; W Herr; P Coulie; U Schmitt; K H Meyer zum Büschenfelde; A Knuth
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396
  10 in total
  2 in total

1.  Targeted tumor cell death induced by autologous tumor-specific T lymphocyte recognition of wild-type p53-derived peptides.

Authors:  Hideo Tsurushima; Yoshihiko Yoshii; Kam W Leong; Tadao Ohno
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.

Authors:  H Tsurushima; S Q Liu; K Tuboi; A Matsumura; Y Yoshii; T Nose; K Saijo; T Ohno
Journal:  Jpn J Cancer Res       Date:  1999-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.